{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-088752","form_type":"8-K","ticker":"SANA","cik":"0001770121","company_name":"Sana Biotechnology, Inc.","filed_at":"2025-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.642788+00:00","generated_at":"2026-05-18T23:56:47.968015+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Sana reports positive six-month data for islet cell therapy in type 1 diabetes without immunosuppression","bullets":["Six-month results: transplanted allogeneic islet cells (UP421) safe, survive, evade immune system, produce insulin without immunosuppression.","C-peptide detectable fasting and increases with mixed meal tolerance test, confirming insulin secretion; MRI shows graft survival at 6 months.","No safety issues; HIP-modified cells evade both allogeneic and autoimmune responses in type 1 diabetes patient.","Sana plans to file IND for SC451 (stem cell-derived HIP islet therapy) as soon as next year, incorporating UP421 learnings.","Data presented at ADA 85th Scientific Sessions; study funded by Helmsley Charitable Trust, partnership with Uppsala University Hospital."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-088752","json":"https://secwatch.observer/filing/0000950170-25-088752.json","markdown":"https://secwatch.observer/filing/0000950170-25-088752.md","text":"https://secwatch.observer/filing/0000950170-25-088752.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770121/000095017025088752/0000950170-25-088752-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770121/000095017025088752/sana-20250623.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T23:56:47.968015+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}